Your browser doesn't support javascript.
loading
Per- and polyfluoroalkyl substances as persistent pollutants with metabolic and endocrine-disrupting impacts.
Gaillard, Lucas; Barouki, Robert; Blanc, Etienne; Coumoul, Xavier; Andréau, Karine.
Afiliação
  • Gaillard L; Université Paris Cité - INSERM UMR 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France.
  • Barouki R; Université Paris Cité - INSERM UMR 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France.
  • Blanc E; Université Paris Cité - INSERM UMR 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France.
  • Coumoul X; Université Paris Cité - INSERM UMR 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France. Electronic address: xavier.coumoul@u-paris.fr.
  • Andréau K; Université Paris Cité - INSERM UMR 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, France.
Article em En | MEDLINE | ID: mdl-39181731
ABSTRACT
The widespread use of per- and polyfluoroalkyl substances (PFASs), and their resistance to degradation, renders human exposure to them inevitable. PFAS exposure disturbs endocrine function, potentially affecting cognitive development in newborns through thyroid dysfunction during pregnancy. Recent studies reveal varying male and female reproductive toxicity across PFAS classes, with alternative analogs affecting sperm parameters and legacy PFASs correlating with conditions like endometriosis. Metabolically, PFASs exposure is linked to metabolic disorders, including obesity, type 2 diabetes mellitus (T2DM), dyslipidemia, and liver toxicity, particularly in early childhood. This review focuses on the endocrine-disrupting impact of PFASs, particularly on fertility, thyroid, and metabolic functions. We highlight the complexity of the PFAS issue, given the large number of molecules and their extremely diverse mixed effects.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Trends Endocrinol Metab Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Trends Endocrinol Metab Ano de publicação: 2024 Tipo de documento: Article